Immunohistochemical (IHC) biomarkers like Ki-67, p53, and E-cadherin correlate with tumor aggressiveness; a high Ki-67 and low E-cadherin indicate greater proliferation and invasiveness. Here, CDH1 is linked to neoplasm.